Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial.
Saraux A, Le Henaff C, Dernis E, Carvajal-Alegria G, Tison A, Quere B, Petit H, Felten R, Jousse-Joulin S, Guellec D, Marhadour T, Kervarrec P, Cornec D, Querellou S, Nowak E, Souki A, Devauchelle-Pensec V. Saraux A, et al. Among authors: querellou s. Lancet Rheumatol. 2023 Dec;5(12):e728-e735. doi: 10.1016/S2665-9913(23)00246-1. Lancet Rheumatol. 2023. PMID: 38251563 Clinical Trial.
Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria.
Le Roux PY, Gastinne T, Le Gouill S, Nowak E, Bodet-Milin C, Querellou S, Mahe B, Dubruille V, Blin N, Salaun PY, Bodere-Kraeber F. Le Roux PY, et al. Among authors: querellou s. Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1064-71. doi: 10.1007/s00259-011-1741-0. Epub 2011 Feb 10. Eur J Nucl Med Mol Imaging. 2011. PMID: 21308370
Early prediction of survival following induction chemotherapy with DCF (docetaxel, cisplatin, 5-fluorouracil) using FDG PET/CT imaging in patients with locally advanced head and neck squamous cell carcinoma.
Abgral R, Le Roux PY, Keromnes N, Rousset J, Valette G, Gouders D, Leleu C, Mollon D, Nowak E, Querellou S, Salaün PY. Abgral R, et al. Among authors: querellou s. Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1839-47. doi: 10.1007/s00259-012-2213-x. Epub 2012 Aug 16. Eur J Nucl Med Mol Imaging. 2012. PMID: 22895863 Clinical Trial.
Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment.
Palard-Novello X, Querellou S, Gouillou M, Saraux A, Marhadour T, Garrigues F, Abgral R, Salaün PY, Devauchelle-Pensec V. Palard-Novello X, et al. Among authors: querellou s. Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):773-9. doi: 10.1007/s00259-015-3287-z. Epub 2016 Jan 11. Eur J Nucl Med Mol Imaging. 2016. PMID: 26753600
Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.
Devauchelle-Pensec V, Berthelot JM, Cornec D, Renaudineau Y, Marhadour T, Jousse-Joulin S, Querellou S, Garrigues F, De Bandt M, Gouillou M, Saraux A. Devauchelle-Pensec V, et al. Among authors: querellou s. Ann Rheum Dis. 2016 Aug;75(8):1506-10. doi: 10.1136/annrheumdis-2015-208742. Epub 2016 Feb 29. Ann Rheum Dis. 2016. PMID: 26929219 Free PMC article. Clinical Trial.
[18F]FDG PET/CT for therapeutic assessment of Abatacept in early-onset polymyalgia rheumatica.
Allard B, Devauchelle-Pensec V, Saraux A, Nowak E, Tison A, Boukhlal S, Guellec D, Jousse-Joulin S, Cornec D, Marhadour T, Le Pennec R, Salaün PY, Querellou S. Allard B, et al. Among authors: querellou s. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1297-1309. doi: 10.1007/s00259-023-06557-x. Epub 2023 Dec 14. Eur J Nucl Med Mol Imaging. 2024. PMID: 38095675
52 results